Greater Efficacy of Avalglucosidase vs Alglucosidase Alfa in Adult Pompe Disease? The Jury Is Still Out

Affiliations

¹ From the Department of Neurology (M.d.V.), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (Z.A.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel. m.devisser@amsterdamumc.nl.
² From the Department of Neurology (M.d.V.), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (Z.A.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

Editorial

Marianne de Visser et al. Neurology. 2022.

. 2022 Aug 1;99(5):183-184.

doi: 10.1212/WNL.0000000000200821.

¹ From the Department of Neurology (M.d.V.), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (Z.A.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel. m.devisser@amsterdamumc.nl.
² From the Department of Neurology (M.d.V.), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, the Netherlands; and Department of Neurology (Z.A.), Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

No abstract available

Publication types